An increased lung cancer risk associated with codon 72 polymorphism in the TP53 gene and human papillomavirus infection in Mazandaran province, Iran

Lung Cancer

Volumn 56, Issue 2, 2007, Pages 145-151

  Nadji, Seyed Alireza ^a,b   Mahmoodi, Mahmood ^a   Ziaee, Abed Ali ^c   Naghshvar, Farshad ^d   Torabizadeh, Jila ^d   Yahyapour, Yousef ^a   Nategh, Rakhshandeh ^a   Mokhtari Azad, Talat ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF TEHRAN   (Iran)

^d MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Codon 72 polymorphism; Human papillomavirus; Iran; Lung cancer risk; TP53 gene

Indexed keywords

ARGININE; PROLINE;

ADULT; AGED; ARTICLE; CANCER PATIENT; CODON; CONTROLLED STUDY; EXON; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; HUMAN TISSUE; IRAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SMOKING; TP53 GENE; WART VIRUS;

CASE-CONTROL STUDIES; CODON; FEMALE; GENES, P53; GENOTYPE; HUMANS; IRAN; LUNG NEOPLASMS; MALE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING;

EID: 34247118262     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2006.12.006     Document Type: Article

References (29)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
2. Ahuja H.G., Testa M.P., and Cline M.J. Variation in the protein coding region of the human p53 gene. Oncogene 5 (1990) 1409-1410
3. Felix C.A., Brown D.L., Mitsudomi T., Ikagaki N., Wong A., Wasserman R., et al. Polymorphism at codon 36 of the p53 gene. Oncogene 9 (1994) 327-328
4. Felley-Bosco E., Weston A., Cawley H.M., Bennet W.P., and Harris C.C. Functional studies of a germ-line polymorphism at codon-47 within the p53 gene. Am J Hum Genet 53 (1993) 752-759
5. Wang Y.C., Chen C.Y., Chen S.K., Chang Y.Y., and Lin P. p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis. Clin Cancer Res 5 (1999) 129-134
6. Malkin D., Jolly K.W., Barbier N., Look A.T., Friend S.H., Gebhardt M.C., et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasm. Science 250 (1990) 1233-1238
7. Weston A., Perrin L.S., Forrester K., Hoover R.N., Trump B.F., Harris C.C., et al. Allelic frequency of a p53 polymorphism in human lung cancer. Cancer Epidemiol Biomark Prev 1 (1992) 481-483
8. Kawajiri K., Nakachi K., Imai K., Watanabe J., and Hayashi S.I. Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer. Carcinogenesis 14 (1993) 1085-1089
9. Murata M., Tagawa M., Kimura M., Kimura H., Watanabe S., and Saisho H. Analysis of a germ line polymorphism of the p53 gene in lung cancer patients; discrete results with smoking history. Carcinogenesis 17 (1996) 261-264
10. Jin X., Wu X., Roth J.A., Amos C.I., King T.M., Branch C., et al. Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. Carcinogenesis 16 (1995) 2205-2208
11. Beckman G., Birgander R., Själander A., Saha N., Holmberg P.A., Kivela A., et al. Is p53 polymorphism maintained by natural selection?. Hum Hered 44 (1994) 266-270
12. Weston A., Ling-Cawley H.M., Caporaso N.E., Bowman E.D., Hoover R.N., Trump B.F., et al. Determination of the allelic frequencies of an L-myc and a p53 polymorphism in human lung cancer. Carcinogenesis 15 (1994) 583-587
13. Birgander R., Själander A., Rannug A., Alexandrie A.K., Sundberg M.I., Seidegard J., et al. P53 polymorphisms and haplotypes in lung cancer. Carcinogenesis 16 (1995) 2233-2236
14. Nadji SA, Mokhtari-Azad T, Mahmoodi M, Yahyapour Y, Naghshvar F, Torabizadeh J, et al. Relationship between lung cancer and human papillomavirus in north of Iran, Mazandaran Province. Cancer letters 2006; in press.
15. Impraim C.C., Saiki R.K., Erlich H.A., and Teplitz R.L. Analysis of DNA extracted from formalin-fixed, paraffin-embedded tissues by enzymatic amplification and hybridization with sequence-specific oligonucleopeptides. Biochem Biophys Res Commun 142 (1987) 710-716
16. Saiki R.K., Bugawan T.L., Horn G.T., Mullis K.B., and Erlich H.A. Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes. Nature 324 (1986) 163-166
17. Sotlar K., Diemer D., Dethleffs A., Hack Y., Stubner A., Vollmer N., et al. Detection and typing of human papillomavirus by E6 nested multiplex PCR. J Clin Microbiol 42 (2004) 3176-3184
18. Storey A., Thomas M., Kalita A., Harwood C., Gardiol D., Mantovani F., et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393 (1998) 229-234
19. Lam W.K. Lung cancer in Asian women-the environment and genes. Respirology 10 (2005) 408-417
20. Alberg A.J., and Samet J.M. Epidemiology of lung cancer. Chest 123 (2003) 21S-49S
21. To-Figueras J., Gené M., Gómez-Catalàn, Firvida J., Fuentes M., Rodamilans M., et al. Glutathione S-transferase M1 and codon 72 p53 polymorphism in a northwestern Mediterranean population and their relation to lung cancer susceptibility. Cancer Epidemiol Biomarkers Prev 5 (1996) 337-342
22. Irarrázabal C.E., Rojas C., Aracena R., Marquez C., and Gil L. Chilean pilot study on the risk of lung cancer associated with codon 72 polymorphism in the gene of protein p53. Toxicol Lett 144 (2003) 69-76
23. Devesa S.S., Shaw G.L., and Blot W.J. Changing patterns of lung cancer by histologic type. Cancer Epidemiol Biomarkers Prev 1 (1991) 29-34
24. Travis W.D., Travis L.B., and Devesa S.S. Lung cancer. Cancer 75 (1995) 191-202
25. Chen Y.C., Chen J.H., Richard K., Chen P.Y., and Christiani D.C. Lung adenocarcinoma and human papillomavirus infection. Cancer 101 (2004) 1428-1436
26. Syrjänen K.J. HPV infections and lung cancer. J Clin Pathol 55 (2002) 885-891
27. Chiou H.L., Wu M.F., Liaw Y.C., Cheng Y.W., Wong R.H., Chen C.Y., et al. The presence of human papillomavirus type 16/18 DNA in blood circulation may act as a risk marker of lung cancer in Taiwan. Cancer 97 (2003) 1558-1563
28. Cheng Y.W., Chiou H.L., Sheu G.T., Hsieh L.L., Chen J.T., Chen C.Y., et al. The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res 61 (2001) 2799-2803
29. Chang K.W., Chang C.S., Lai K.S., Chou M.J., and Choo K.B. High prevalence of human papillomavirus infection and possible association with betel quid chewing and smoking in oral epidermoid carcinomas in Taiwan. J Med Virol 28 (1989) 57-61